ArticleCancers2022

Discovery of a New CaMKII-Targeted Synthetic Lethal Therapy against Glioblastoma Stem-like Cells.

Jang Mi Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.